Skip to content
value.today

Solid Biosciences Inc.: insider trading

254 trades by 33 directors, officers and 10% owners since 2018, from their SEC Form 4 and 5 filings.

Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$2.7 M
28 sales by 7 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$25 K
1 sale

Insider buying and selling by month

Open-market purchases and sales by value, last three years.

$26.1 M-$2.5 M$0Dec 2023: bought $0 (0 trades), sold $83 K (5 trades)Dec 23Jan 2024: bought $23.9 M (2 trades), sold $39 K (3 trades)May 2024: bought $0 (0 trades), sold $5 K (1 trades)MayJun 2024: bought $8 K (1 trades), sold $0 (0 trades)Oct 2024: bought $0 (0 trades), sold $19 K (1 trades)OctDec 2024: bought $0 (0 trades), sold $132 K (4 trades)Jan 2025: bought $0 (0 trades), sold $21 K (3 trades)Jan 25Feb 2025: bought $26.1 M (3 trades), sold $122 K (7 trades)Mar 2025: bought $10 K (1 trades), sold $0 (0 trades)MarOct 2025: bought $0 (0 trades), sold $17 K (1 trades)Nov 2025: bought $0 (0 trades), sold $14 K (1 trades)NovDec 2025: bought $0 (0 trades), sold $117 K (4 trades)Jan 2026: bought $0 (0 trades), sold $37 K (3 trades)Jan 26Feb 2026: bought $0 (0 trades), sold $2.5 M (20 trades)Oct 2026: bought $0 (0 trades), sold $25 K (1 trades)Oct
Bought (open market)Sold (open market)Hover a month for the totals

Insiders (33)

Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.

Solid Biosciences Inc. insiders
InsiderShares owned directlyBought, 12 mSold, 12 mLatest trade
Gabriel BrooksChief Medical Officer97,241—$288 K
Ian F. SmithDirector141,585——
Alexander CumboPresident and CEO, Director235,405—$984 K
David T. HowtonChief Operating Officer105,077—$434 K
Ilan GanotDirector99,297—$69 K
Jessie HanrahanChief Regulatory Officer74,318—$297 K
Kevin TanCFO & Treasurer99,422—$330 K
Paul HerzichChief Technology Officer72,638—$274 K
Clare KahnDirector2,960——
BCLS SB Investco, LP10% owner———
Joseph EdelmanDirector, 10% owner———
Robert Atchinson10% owner———
Adam KoppelDirector, 10% owner———
Perceptive Xontogeny Venture Fund, LPDirector, 10% owner———
RA Capital Nexus Fund, L.P.Director, 10% owner———
Jennifer MarloweCSO6,998——
Carl Ashley MorrisChief Scientific Officer19,760——
Ra Capital Management, L.P.Director, 10% owner———
Schneider Joel Solomon ZevChief Operating Officer236,270——
RA Capital Healthcare Fund LPDirector, 10% owner———
Peter KolchinskyDirector, 10% owner———
Jennifer Lynn ZiolkowskiCFO, Treasurer & Asst. Secy335,636——
Matthew Bennett ArnoldDirector3.93 M——
Rajeev M. ShahDirector, 10% owner———
Lynette HerschaChief Legal Officer160,859——
Martin I. FreedDirector53,763——
Perceptive Advisors LLCDirector, 10% owner———
Sukumar NagendranDirector34,258——
Juan Andrey ZarurDirector691,105——
Boxer Capital, LLC10% owner3.47 M——
Pedro Alvaro AmorrortuChief Operating Officer153,746——
Jorge Armando QuirozChief Medical Officer228,092——
Gilad David Hayeem10% owner1.95 M——

Trades#

Solid Biosciences Inc.: insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Clare KahnDirectorBuy+1,860$5.340$10 K2,960Form 4
filed Joseph EdelmanDirector, 10% ownerBuyindirect+5.00 M$4.030$20.1 M11.83 MForm 4
filed BCLS SB Investco, LP10% ownerBuyindirect+1.00 M$4.030$4.0 M5.03 MForm 4
filed Robert Atchinson10% ownerBuyindirect+252,545$7.560$1.9 M4.25 MForm 4
filed Clare KahnDirectorBuy+1,100$7.670$8 K1,100Form 4
filed RA Capital Nexus Fund, L.P.Director, 10% ownerBuyindirect+904,160$5.530$5.0 M4.19 MForm 4
filed Perceptive Xontogeny Venture Fund, LPDirector, 10% ownerBuyindirect+3.41 M$5.530$18.9 M6.83 MForm 4
filed Joseph EdelmanDirector, 10% ownerBuyindirect+2.61 M$5.750$15.0 M13.41 MForm 4
filed Peter KolchinskyDirector, 10% ownerBuyindirect+2.21 M$5.750$12.7 M10.92 MForm 4
filed Perceptive Advisors LLCDirector, 10% ownerBuyindirect+2.82 M$4.650$13.1 M6.75 MForm 4
filed Adam KoppelDirectorBuyindirect+300,000$16.00$4.8 M1.99 MForm 4
filed Perceptive Advisors LLCDirector, 10% ownerBuyindirect+1.00 M$16.00$16.0 M3.91 MForm 4
filed Rajeev M. ShahDirectorBuyindirect+1.00 M$16.00—2.69 MForm 4
filed Perceptive Advisors LLCDirector, 10% ownerBuyindirect+20,000$27.33$547 K3.93 MForm 4

Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice